Shaghayegh Haghjooy Javanmard
Overview
Explore the profile of Shaghayegh Haghjooy Javanmard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
247
Citations
2204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zarin B, Rafiee L, Abdollahi S, Vatani M, Hassani M, Sanati-Nezhad A, et al.
Transl Oncol
. 2025 Feb;
53:102303.
PMID: 39904278
Background: Understanding the mechanisms underlying the metastasis of breast cancer cells to the lungs is challenging, and appropriate simulation of the tumor microenvironment with mimetic cancer-stroma crosstalk is essential. β4...
2.
Arshadi S, Pishevar A, Javanbakht M, Javanmard S
Math Biosci
. 2024 Dec;
380:109366.
PMID: 39681157
In this paper, we propose a vascular tumor growth model that combines a phase-field tumor model with a phase-field angiogenesis model. By incorporating various tumor cell species, we capture the...
3.
Kajani A, Pouresmaeili A, Mehrgardi M, Javanmard S
Sci Rep
. 2024 Nov;
14(1):29111.
PMID: 39582076
A simple, one-pot and green method is reported for hydrothermal synthesis of highly fluorescent and magnetic carbon dots (CDs) by using D-glucose, as the carbon source. CDs were fully characterized...
4.
Falahat K, Baradaran Eftekhari M, Javanmard S, Ghalenoee E, Shakeri H
Int J Prev Med
. 2024 Nov;
15:53.
PMID: 39539578
Background: Research impact assessment is already being institutionalized in health research and innovation systems. In developing countries, there are many different research assessment models which have focused more on research...
5.
Erfanian S, Ansari H, Javanmard S, Amini Z, Hajigholami A
BMC Complement Med Ther
. 2024 Sep;
24(1):329.
PMID: 39232773
Background: Breast cancer is one of the most common diseases globally that may have side effects on liver and renal function. Pharmacological treatments to reduce adverse liver and renal effects...
6.
Nedaeinia R, Najafgholian S, Salehi R, Goli M, Ranjbar M, Nickho H, et al.
Cell Death Discov
. 2024 Aug;
10(1):380.
PMID: 39187523
CAFs (cancer-associated fibroblasts) are highly flexible cells of the cancer microenvironment. They produce the extracellular matrix (ECM) constituents that form the structure of the tumor stroma but are also a...
7.
Manteghinejad A, Rasti S, Nasirian M, Javanmard S
Int J Prev Med
. 2024 Aug;
15:18.
PMID: 39170924
Background: Many people worldwide have developed a combination of natural and vaccine-induced immunity to COVID-19. This study investigated whether exposure to SARS-CoV-2 before full vaccination promotes protection against a breakthrough...
8.
Vaseghi G, Shariati L, Najafi M, Malakootikhah Z, Naji Esfahani H, Javanmard S
Adv Biomed Res
. 2024 May;
13:24.
PMID: 38808320
Background: Inositol 1,4,5-trisphosphate receptor (IP3R), a critical calcium ion (Ca2+) regulator, plays a vital role in breast cancer (BC) metabolism. Dysregulated IP3R in BC cells can drive abnormal growth or...
9.
Esmaeili Y, Dabiri A, Mashayekhi F, Rahimmanesh I, Bidram E, Karbasi S, et al.
Biomed Pharmacother
. 2024 Mar;
173:116465.
PMID: 38507955
This study introduces an innovative co-delivery approach using the MCM-co-polymerized nanosystem, integrating chitosan and polyethylene glycol, and targeted by the MUC-1 aptamer (MCM@CS@PEG-APT). This system enables simultaneous delivery of the...
10.
Vafaei Z, Najafian J, Shekarchizadeh M, Mohammadifard N, Mostafavi S, Roohafza H, et al.
J Cancer Res Ther
. 2024 Feb;
19(7):1893-1898.
PMID: 38376294
Background: Many breast cancer (BC) patients experience psychological reactions and may have psychiatric morbidities, especially anxiety and depressive disorders. The aim of this study was to evaluate perceived stress and...